Nitric oxide-derived markers in exhaled breath condensate

New Perspectives in Monitoring Lung Inflammation: Analysis of Exhaled Breath Condensate

Volumn , Issue , 2004, Pages 85-104

  Kharitonov, Sergei A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952290886     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (72)

1. Kharitonov, S.A. and Barnes, P.J., Exhaled markers of pulmonary disease, Am. J. Respir. Crit. Care Med., 163, 1693, 2001.
2. Kharitonov, S.A. and Barnes, P.J., Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease, Curr. Allergy Asthma Rep., 3, 121, 2003.
3. Kharitonov, S.A. and Barnes, P.J., Biomarkers of some pulmonary diseases in exhaled breath, Biomarkers, 7, 1, 2002.
4. Kharitonov, S.A. and Barnes, P.J., Exhaled markers of inflammation, Curr. Opin. Allergy Clin. Immunol., 1, 217, 2001.
5. Bartberger, M.D. et al., The reduction potential of nitric oxide (NO) and its importance to NO biochemistry, Proc. Natl. Acad. Sci. U.S.A., 99, 10958, 2002.
6. Hanazawa, T., Kharitonov, S.A., and Barnes, P.J., Increased nitrotyrosine in exhaled breath condensate of patients with asthma, Am. J. Respir. Crit. Care Med., 162, 1273, 2000.
7. Maziak, W. et al., Exhaled nitric oxide in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 157, 998, 1998.
8. Gunther, M.R., Sturgeon, B.E., and Mason, R.P., Nitric oxide trapping of the tyrosyl radical-chemistry and biochemistry, Toxicology, 177, 1, 2002.
9. Kuo. W.N. and Kocis, J.M., Nitration/S-nitrosation of proteins by peroxynitritetreatment and subsequent modification by glutathione S-transferase and glutathione peroxidase, Mol. Cell. Biochem., 233, 57, 2002.
10. Aulak, K.S. et al., Proteomic method identifies proteins nitrated in vivo during inflammatory challenge, Proc. Natl. Acad. Sci. U.S.A., 98, 12056, 2001.
11. Brown, G.C. and Borutaite, V., Nitric oxide, mitochondria, and cell death, IUBMB Life, 52, 189, 2001.
12. Bucchieri, F. et al., Asthmatic bronchial epithelium is more susceptible to oxidantinduced apoptosis, Am. J. Respir. Cell Mol. Biol., 27, 179, 2002.
13. Tomita, K. et al., Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am. J. Respir. Crit. Care Med., 166, 724, 2002.
14. Harju, T. et al., Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers’ lung, Am. J. Respir. Crit. Care Med., 166, 754, 2002.
15. Yang, S. et al., Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice, Am. J. Respir. Cell. Mol. Biol., 24, 527, 2001.
16. Souza, J.M. et al., Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys., 380, 360, 2000.
17. Davis, K.L. et al., Novel effects of nitric oxide, Annu. Rev. Pharmacol. Toxicol., 41, 203, 2001.
18. Eiserich, J.P. et al., Myeloperoxidase, a leukocyte-derived vascular NO oxidase, Science, 296, 2391, 2002.
19. Saleh, D. et al., Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid, FASEB J., 12, 929, 1998.
20. Ichinose, M. et al., Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways, Am. J. Respir. Crit. Care Med., 162, 701, 2000.
21. Kamisaki, Y. et al., An activity in rat tissues that modifies nitrotyrosine-containing proteins, Proc. Natl. Acad. Sci. U.S.A., 95, 11584, 1998.
22. Cooke, C.L. and Davidge, S.T., Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells, Am. J. Physiol. Cell Physiol., 282, C395, 2002.
23. Ashutosh, K. et al., Use of nitric oxide inhalation in chronic obstructive pulmonary disease, Thorax, 55, 109, 2000.
24. Guo, X. et al., Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population, Eur. Respir. J., 18, 482, 2001.
25. Lawler, J.M. and Song, W., Specificity of antioxidant enzyme inhibition in skeletal muscle to reactive nitrogen species donors, Biochem. Biophys. Res. Commun., 294, 1093, 2002.
26. Gow, A.J. et al., Basal and stimulated protein S-nitrosylation in multiple cell types and tissues, J. Biol. Chem., 277, 9637, 2002.
27. Glare, E.M. et al., Beta-actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels Thorax, 57, 765, 2002.
28. Kasahara, Y. et al., Inhibition of VEGF receptors causes lung cell apoptosis and emphysema, J. Clin. Invest., 106, 1311, 2000.
29. Gaston, B. et al., Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure, Lancet, 351, 1317, 1998.
30. Haqqani, A.S., Kelly, J.F, and Birnboim, H.C., Selective nitration of histone tyrosine residues in vivo in mutatect tumors, J. Biol. Chem., 277, 3614, 2002.
31. Ito, K. and Adcock, I.M., Histone acetylation and histone deacetylation, Mol. Biotechnol., 20, 99, 2002.
32. Ito, K. et al., Expression and activity of histone deacetylases in human asthmatic airways, Am. J. Respir. Crit. Care Med., 166, 392, 2002.
33. Kharitonov, S.A. and Barnes, P.J., Clinical aspects of exhaled nitric oxide, Eur. Respir. J., 16, 781, 2000.
34. Corradi, M. et al., Nitrate in exhaled breath condensate of patients with different airway diseases, Nitric Oxide, 8, 26, 2003.
35. Ito, K. et al., Real-time measurement of peroxynitrite in exhaled breath condensate, Eur. Respir. J., 22, Suppl. 45, 448s, 2003.
36. Kharitonov, S.A. et al., Acute and chronic effects of cigarette smoking on exhaled nitric oxide, Am. J. Respir. Crit. Care Med., 152, 609, 1995.
37. Hoyt, J.C. et al., Cigarette smoke decreases inducible nitric oxide synthase in lung epithelial cells, Exp. Lung Res., 29, 17, 2003.
38. Balint, B. et al., Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke, Thorax, 56, 456, 2001.
39. Olin, A.C. et al., Increased nitric oxide in exhaled air after intake of a nitrate-rich meal, Respir. Med., 95, 153, 2001.
40. Sapienza, M.A. et al., Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects, Thorax, 53, 172, 1998.
41. Kharitonov, S.A. et al., L-arginine increases exhaled nitric oxide in normal human subjects, Clin. Sci. (Lond), 88, 135, 1995.
42. Kharitonov, S.A. et al., Increased nitric oxide in exhaled air of asthmatic patients, Lancet, 343, 133, 1994.
43. Yates, D.H. et al., Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide, Am. J. Respir. Crit. Care Med., 152, 892, 1995.
44. Holden, W.E. et al., Temperature conditioning of nasal air: effects of vasoactive agents and involvement of nitric oxide, J. Appl. Physiol., 87, 1260, 1999.
45. Sippel, J.M., Giraud, G.D., and Holden, W.E., Nasal administration of the nitric oxide synthase inhibitor L-NAME induces daytime somnolence, Sleep, 22, 786, 1999.
46. Hansel, T.T. et al., A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics, FASEB J., 17, 1298, 2003.
47. Nightingale, J.A., Rogers, D.F., and Barnes, P.J., Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects, Thorax, 54, 1061, 1999.
48. Latzin, P. and Griese, M., Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide, Eur. J. Med. Res., 7, 353, 2002.
49. Stamler, J.S., S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups, Curr. Topics Microbiol. Immunol., 196, 19, 1995.
50. van der Vliet, A. et al., Reactive nitrogen species and tyrosine nitration in the respiratory tract. Epiphenomena or a pathobiologic mechanism of disease? Am. J. Respir. Crit. Care Med., 160, 1, 1999.
51. Maestrelli, P. et al., Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients, Eur. Respir. J., 21, 971, 2003.
52. Sugiura, H. et al., Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD, Thorax, 58, 299, 2003.
53. Hunt, J. et al., Condensed expirate nitrite as a home marker for acute asthma, Lancet, 346, 1235, 1995.
54. Gabazza, E.C. et al., Role of nitric oxide in airway remodelling, Clin. Sci. (Colch), 98, 291, 2000.
55. Hanazawa, T. et al., Nitrotyrosine and cystenyl leukotrienes in breath condensates are increased after withdrawal of steroid treatment in patients with asthma, Am. J. Respir. Crit. Care Med., 161, A919, 2000.
56. Ganas, K. et al., Total nitrite/nitrate in expired breath condensate of patients with asthma, Respir. Med., 95, 649, 2001.
57. Formanek, W. et al., Elevated nitrite in breath condensates of children with respiratory disease, Eur. Respir. J., 19, 487, 2002.
58. Kharitonov, S.A. et al., Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma, Thorax, 57, 889, 2002.
59. Chambers, D.C., Tunnicliffe, W.S., and Ayres, J.G., Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations, Thorax, 53, 677, 1998.
60. Paska, C. et al., Increased expression of inducible NOS in peripheral lung of severe COPD patients, Eur. Respir. J., 20, 95s, 2002.
61. Brindicci, C. et al., Extended exhaled NO measurements at different exhalation flows may differentiate between bronchial and alveolar inflammation in patients with asthma and COPD, Eur. Respir. J., 20, 174s, 2002.
62. Csoma, Z. et al., Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia, Chest, 124, 633, 2003.
63. Ho, L.P., Innes, J.A., and Greening, A.P., Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide, Thorax, 53, 680, 1998.
64. Linnane, S.J. et al., Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis, Am. J. Respir. Crit. Care Med., 158, 207, 1998.
65. Balint, B. et al., Increase nitrotyrosine in exhaled breath condensate in cystic fibrosis, Eur. Respir. J., 17, 1201, 2001.
66. Jones, K.L. et al., Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum, Pediatr. Pulmonol., 30, 79, 2000.
67. Grasemann, H. et al., Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function, J. Pediatr., 135, 770, 1999.
68. Corradi, M. et al., Nitrosothiols and nitrite in exhaled breath condensate of patients with cystic fibrosis, Am. J. Respir. Crit. Care Med., 159, A682, 1999.
69. Gessner, C. et al., Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury, Chest, 124, 1046, 2003.
70. O’Donnell, D.M. et al., Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis, Am. J. Respir. Crit. Care Med., 156, 1892, 1997.
71. Gaut, J.P. et al., Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry, Anal. Biochem., 300, 252, 2002.
72. Hanazawa, T. et al., Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis, J. Allergy Clin. Immunol., 105, 58, 2000.